94 related articles for article (PubMed ID: 15289903)
21. [Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer].
Qi T; Wang Q; Zheng L; Yang HL; Bao J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):754-7. PubMed ID: 18504197
[TBL] [Abstract][Full Text] [Related]
22. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection.
Jung YJ; Kim YJ; Kim LH; Lee SO; Park BL; Shin HD; Lee HS
Intervirology; 2007; 50(5):369-76. PubMed ID: 17938571
[TBL] [Abstract][Full Text] [Related]
23. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z
Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302
[TBL] [Abstract][Full Text] [Related]
24. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
Li CY; Liu JH; Huang BJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
[TBL] [Abstract][Full Text] [Related]
25. MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer.
Singh H; Jain M; Mittal B
Gynecol Oncol; 2008 Jul; 110(1):71-5. PubMed ID: 18448157
[TBL] [Abstract][Full Text] [Related]
26. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
27. [Association between CTLA-4 gene polymorphism and susceptibility to cervical cancer].
Li H; Zhou YF; Guo HY; Sun T; Zhang WH; Lin DX
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):681-4. PubMed ID: 22340049
[TBL] [Abstract][Full Text] [Related]
28. No association between Fas A/G polymorphism and therapeutic effects induced by methimazole treatment for Graves' disease in Northern Chinese.
Li P; Li Q; Chen L; Sun Y; Zhang J
Pharmazie; 2008 Oct; 63(10):748-50. PubMed ID: 18972838
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients.
Gudleviciene Z; Didziapetriene J; Ramael M; Uleckiene S; Valuckas KP
Gynecol Oncol; 2006 Sep; 102(3):530-3. PubMed ID: 16488468
[TBL] [Abstract][Full Text] [Related]
30. Polymorphism of Fas and Fas ligand in preterm premature rupture of membranes in singleton pregnancies.
Fuks A; Parton LA; Polavarapu S; Netta D; Strassberg S; Godi I; Hsu CD
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1132-6. PubMed ID: 16157125
[TBL] [Abstract][Full Text] [Related]
31. [Association between Fas/Fas L genes promoter polymorphisms and pathogenic risk of cervical cancer].
Li H; Guo HY; Sun T; Zhou YF; Lin DX; Zhang WH; Qiao J
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):38-41. PubMed ID: 19538867
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a Apo-1/Fas promoter polymorphism in Korean stroke patients.
Seo JC; Han SW; Yin CS; Koh HK; Kim CH; Kim EH; Leem KH; Lee HS; Park HJ; Kim SA; Choe BK; Lee HJ; Yim SV; Kim CJ; Chung JH
Exp Mol Med; 2002 Sep; 34(4):294-8. PubMed ID: 12515395
[TBL] [Abstract][Full Text] [Related]
33. [Analyzing of Fas-670 gene polymorphism in hepatocarcinoma tissue].
Zhang J; Liu Q; Mao HT
Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):630-1. PubMed ID: 19719928
[No Abstract] [Full Text] [Related]
34. Promoter polymorphism in the matrix metalloproteinase-1 and risk of cervical cancer in Korean women.
Ju W; Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Cancer Lett; 2005 Jan; 217(2):191-6. PubMed ID: 15617836
[TBL] [Abstract][Full Text] [Related]
35. The -463G/A polymorphism in myeloperoxidase gene and cervical cancer.
Mustea A; Heinze G; Sehouli J; Koensgen D; Wolf A; Gutu L; Sofroni D; Pirvulescu C; Braicu EI; Schuster E; Zeillinger R; Tong D
Anticancer Res; 2007; 27(3B):1531-5. PubMed ID: 17595772
[TBL] [Abstract][Full Text] [Related]
36. Exposure to wood smoke, HPV infection, and genetic susceptibility for cervical neoplasia among women in Colombia.
Sierra-Torres CH; Arboleda-Moreno YY; Orejuela-Aristizabal L
Environ Mol Mutagen; 2006 Aug; 47(7):553-61. PubMed ID: 16795085
[TBL] [Abstract][Full Text] [Related]
37. MHC class I chain-related gene A (MICA) polymorphism and the different histological types of cervical cancer.
Chen JR; Lee YJ; Chen T; Wang KL; Dang CW; Chang SC; Liu HF; Yang YC
Neoplasma; 2005; 52(5):369-73. PubMed ID: 16151576
[TBL] [Abstract][Full Text] [Related]
38. Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism.
Catarino R; Matos A; Pinto D; Pereira D; Craveiro R; Vasconcelos A; Lopes C; Medeiros R
Cancer Genet Cytogenet; 2005 Jul; 160(1):49-54. PubMed ID: 15949570
[TBL] [Abstract][Full Text] [Related]
39. A single-nucleotide polymorphism (-670) of the maternal Fas gene is associated with intrauterine growth restriction.
Robinson R; Hsu CD; Chesebro AL; Nguyen J; Ali N; Maramreddy H; Parton LA
Am J Obstet Gynecol; 2009 Dec; 201(6):620.e1-4. PubMed ID: 19716115
[TBL] [Abstract][Full Text] [Related]
40. The FAS/cd95 promoter single-nucleotide polymorphism -670 A/G and lupus erythematosus.
Molin S; Weiss EH; Ruzicka T; Messer G
Clin Exp Dermatol; 2012 Jun; 37(4):425-7. PubMed ID: 22299671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
